AU4324089A - Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product - Google Patents

Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product

Info

Publication number
AU4324089A
AU4324089A AU43240/89A AU4324089A AU4324089A AU 4324089 A AU4324089 A AU 4324089A AU 43240/89 A AU43240/89 A AU 43240/89A AU 4324089 A AU4324089 A AU 4324089A AU 4324089 A AU4324089 A AU 4324089A
Authority
AU
Australia
Prior art keywords
product
cancer therapy
peptide antagonists
mas oncogene
mas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43240/89A
Other languages
English (en)
Inventor
Michel Goedert
Michael Robert Hanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU4324089A publication Critical patent/AU4324089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU43240/89A 1988-09-24 1989-09-22 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product Abandoned AU4324089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888822483A GB8822483D0 (en) 1988-09-24 1988-09-24 Developments relating to mas oncogene
GB8822483 1988-09-24

Publications (1)

Publication Number Publication Date
AU4324089A true AU4324089A (en) 1990-04-18

Family

ID=10644185

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43240/89A Abandoned AU4324089A (en) 1988-09-24 1989-09-22 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product

Country Status (3)

Country Link
AU (1) AU4324089A (fr)
GB (1) GB8822483D0 (fr)
WO (1) WO1990003181A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670737A4 (fr) * 1992-03-26 1996-05-29 Gensia Inc Therapie in vivo recourant a des peptides.
ES2183004T3 (es) * 1995-08-02 2003-03-16 Univ Newcastle Ventures Ltd Compuestos de benzimidazol.
AU5473201A (en) * 2000-03-24 2001-10-03 Bayer Aktiengesellschaft Regulation of human mas oncogene-related g protein-coupled receptor
JP2003530834A (ja) * 2000-03-27 2003-10-21 ピーイー コーポレーション （エヌワイ） 単離した癌原遺伝子サブファミリーに属するヒトｇタンパク質共役受容体、ヒトｇｐｃｒタンパク質をコード化している核酸分子、及びそれらの使用
CA2748340C (fr) * 2008-12-29 2017-01-24 Trevena, Inc. Effecteurs de la .beta.-arrestine, compositions en contenant et leurs procedes d'utilisation
KR20140132340A (ko) 2012-01-31 2014-11-17 트레베나, 인코포레이티드. β-어레스틴 작동자 및 조성물과 이의 사용방법
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
CA2948858A1 (fr) 2014-05-19 2015-11-26 Trevena, Inc. Synthese d'effecteurs de la beta-arrestine

Also Published As

Publication number Publication date
GB8822483D0 (en) 1988-10-26
WO1990003181A3 (fr) 1990-05-03
WO1990003181A2 (fr) 1990-04-05

Similar Documents

Publication Publication Date Title
AU649605B2 (en) Retinal, derivatives and their therapeutic use
AU7813191A (en) Novel immunoconjugates and methods for their use in tumor therapy
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
AU6734990A (en) Freeze-dried dosage forms and methods for preparing the same
HK1009646A1 (en) Phthalimidohexanperacid process for preparing the same and use thereof
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
ZA899725B (en) N-aryl-azetidinones,their preparation process and their use as elastage inhibitors
GB8920132D0 (en) Adhesive dressing,its preparation and use
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
AU1581388A (en) Anti-tumor platinum complexes, their preparation and their therapeutic use
EP0419409A3 (en) Iridium complexes, process for their preparation and their use
AU4324089A (en) Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product
AU3517489A (en) Imidazoquinoxaline compounds and their preparation and use
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
AU2596888A (en) Peptide structures, immunogens containing them and their uses in the control of fertility
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
HRP960117B1 (en) Bicyclic compounds, their preparation and use in pharmaceutical preparations
AU1807492A (en) New hetaryloxy-beta-carbolines, their production and use in pharmaceutical agents
AU5704490A (en) Renin-inhibiting peptides, processes for their preparation and their use in medicaments
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
IL86796A0 (en) Peptide derivatives,their preparation and their use
AU627033B2 (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives, their preparation and their application in therapy
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases